Nurses in particular do not seem to be fans of the COVID-19 vaccine ...

After a federal judge blocked Health Secretary Robert F. Kennedy Jr.’s vaccine policies, the Justice Department has yet to ...

Total protection for when respiratory illness season hits. We may be inching toward that reality. A new paper published in ...

The FDA is reviewing the first mRNA flu vaccine for adults 50 and older. Learn how this technology could lead to faster and ...

The EMA approved Moderna's mRNA COVID-19 and flu vaccine, but US political battles and funding cuts threaten the future of mRNA vaccine innovation. Talha Burki reports.

By Bhanvi Satija LONDON, April 1 (Reuters) - Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated ...

Add Yahoo as a preferred source to see more of our stories on Google. A universal vaccine for cold, flu, Covid and allergies has moved a significant step closer, scientists believe. Christina ...

GoodRx, a platform for medication savings, is tracking prescription fills for medications that treat seasonal viral respiratory infections. The tracker includes fills for: To this end, GoodRx Research ...

Flu and COVID and allergies, oh my! With a record-breaking flu season still underway — and spring allergies just around the corner — you may find your medicine cabinet packed to the brim with ...

Flu and Covid, including a new variant called BA.3.2, nicknamed “cicada,” are still circulating across the U.S. in 2026. How ...

A deadly flu surge is sweeping Australia, with doctors fearing a repeat of last year’s horror season that overwhelmed ...

The COVID-19 vaccine boom made fortunes almost overnight—and destroyed them just as fast. Moderna (NASDAQ: MRNA) has fallen 58.2% over five years. BioNTech (NASDAQ: BNTX) is down 10.9% over the same ...